CRTX
Cortexyme, Inc.
Set alert
1.95 0.00 0.00%
1.86 Day range 1.97
52-week range unavailable
- Open
- 1.91
- Prev close
- 1.95
- Mkt cap
- 70.49M
- Vol
- 272.21K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.86
- High
- 1.97
- Forward P/E
- -1.07
- Beta
- 1.40
- Short ratio
- 6.84
- Inst. own
- 40.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2022
- 50-d avg
- 2.41
- 200-d avg
- 6.70
- 1y target
- 22.25
Financial health
Altman Z-Score
-0.98 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.2×
FY 2017 5y median -4.2× FY 2025
P/S 0.0×
FY 2017 5y median 0.0× FY 2025
P/B -2.7×
FY 2017 5y median 3.2× FY 2025
P/FCF -2.3×
FY 2017 5y median -6.0× FY 2025
EV/EBITDA 776×
FY 2017 5y median -3.4× FY 2025
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -42.8%
FY 2017 5y median -16.8% FY 2025
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2025
ROE 235.1%
FY 2017 5y median -44.6% FY 2025
ROIC -85.0%
FY 2017 5y median -53.4% FY 2025
ROA -89.8%
FY 2017 5y median -49.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2025
Operating Income -1.4%
FY 2017 FY 2025
EPS (diluted) -28.2%
FY 2017 FY 2025
Free Cash Flow -29.9%
FY 2017 FY 2025
Financial Health
Current Ratio 0.5×
FY 2017 5y median 7.9× FY 2025
Quick Ratio 0.5×
FY 2017 5y median 7.9× FY 2025
Debt / Equity -0.5×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 88.4×
FY 2017 5y median 1.3× FY 2025
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31